Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M; Expert Rater Panel; von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. Karschnia P, et al. Among authors: van den bent m. Lancet Oncol. 2023 Nov;24(11):e438-e450. doi: 10.1016/S1470-2045(23)00453-9. Lancet Oncol. 2023. PMID: 37922934 Free PMC article. Review.
Changing paradigms--an update on the multidisciplinary management of malignant glioma.
Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Among authors: van den bent mj. Oncologist. 2006 Feb;11(2):165-80. doi: 10.1634/theoncologist.11-2-165. Oncologist. 2006. PMID: 16476837 Free article. Review.
Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.
Wick W, Puduvalli VK, Chamberlain MC, van den Bent MJ, Carpentier AF, Cher LM, Mason W, Weller M, Hong S, Musib L, Liepa AM, Thornton DE, Fine HA. Wick W, et al. Among authors: van den bent mj. J Clin Oncol. 2010 Mar 1;28(7):1168-74. doi: 10.1200/JCO.2009.23.2595. Epub 2010 Feb 1. J Clin Oncol. 2010. PMID: 20124186 Free PMC article. Clinical Trial.
Bevacizumab and recurrent malignant gliomas: a European perspective.
Wick W, Weller M, van den Bent M, Stupp R. Wick W, et al. Among authors: van den bent m. J Clin Oncol. 2010 Apr 20;28(12):e188-9; author reply e190-2. doi: 10.1200/JCO.2009.26.9027. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159801 Free article. No abstract available.
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Wen PY, et al. Among authors: van den bent mj. J Clin Oncol. 2010 Apr 10;28(11):1963-72. doi: 10.1200/JCO.2009.26.3541. Epub 2010 Mar 15. J Clin Oncol. 2010. PMID: 20231676
Molecular diagnostics of gliomas: the clinical perspective.
Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M. Tabatabai G, et al. Among authors: van den bent mj. Acta Neuropathol. 2010 Nov;120(5):585-92. doi: 10.1007/s00401-010-0750-6. Epub 2010 Sep 23. Acta Neuropathol. 2010. PMID: 20862485 Review.
530 results